Am. J. Respir. Crit. Care Med., Volume 158, Number 3, September 1998, 691-699

Pharmacologic Treatment of Sleep-disordered Breathing

DAVID W. HUDGEL and SITTHEP THANAKITCHARU

Case Western Reserve University, Cleveland, Ohio; and Mahidol University, Ramathibodi Hospital, Bangkok, Thailand

Available literature on the use of pharmacologic agents for the treatment of sleep-disordered breathing was reviewed by evidenced-based methodology. Evidence tables were created and studies were graded according to study design and the number of subjects included. Scores for each group of studies evaluating each pharmacologic agent were established so that the quality of research for different drugs could be compared. The use of various ventilatory stimulants, psychotropic drugs, and antihypertensive agents were reviewed. The most objective data are available on theophylline and opioid antagonist/nicotine groups. Although more controlled studies would be helpful, relatively clear-cut indications for the use of ventilatory stimulants exist for hypercapnic obesity-hypoventilation patients (medroxyprogesterone), myxedema (thyroid replacement), central apnea (acetazolamide), and periodic breathing in congestive heart failure (theophylline). Few randomized, well-controlled trials have been published that evaluate pharmacologic agents in the treatment of classic OSA. To date, no one agent stands out as being useful for OSA. Future research will need to characterize subjects so that various subsets of patients can be tried on one or on a combination of various pharmacologic agents.

This article has been cited by other articles:

				M. Younes, M. Ostrowski, R. Atkar, J. Laprairie, A. Siemens, and P. Hanly Mechanisms of breathing instability in patients with obstructive sleep apnea J Appl Physiol, December 1, 2007; 103(6): 1929 - 1941. [Abstract] [Full Text] [PDF]

				S. Sood, J. L. Morrison, H. Liu, and R. L. Horner Role of Endogenous Serotonin in Modulating Genioglossus Muscle Activity in Awake and Sleeping Rats Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1338 - 1347. [Abstract] [Full Text] [PDF]

				C F Ryan Sleep {middle dot} 9: An approach to treatment of obstructive sleep apnoea/hypopnoea syndrome including upper airway surgery Thorax, July 1, 2005; 60(7): 595 - 604. [Abstract] [Full Text] [PDF]

				M. Wagenaar, P. Je Vos, Y.F. Heijdra, L.J. Teppema, and H.T.M. Folgering Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients Eur. Respir. J., November 1, 2002; 20(5): 1130 - 1137. [Abstract] [Full Text] [PDF]

				A Smyth and M Riley Chronic respiratory failure: an unusual cause and treatment Thorax, September 1, 2002; 57(9): 835 - 836. [Abstract] [Full Text] [PDF]

				H. KIWULL-SCHONE, M. WIEMANN, S. FREDE, D. BINGMANN, K. J. WIRTH, U. HEINELT, H.-J. LANG, and P. KIWULL A Novel Inhibitor of the Na+/H+ Exchanger Type 3 Activates the Central Respiratory CO2 Response and Lowers the Apneic Threshold Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1303 - 1311. [Abstract] [Full Text] [PDF]